Conference abstractPublished 5 Sep 2011
HPV genotype in prognosis of Cervical Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We fi rst established our methodology using SPF1/GP6+ PCR followed by hybridization with a genechip (Easychip® HPV Blot, King Car, Taiwan) for paraffi n-embedded tissue. Consecutive patients treated for cervical carcinoma of International Federation of Gynecology and Obstetrics stage I?IV between 1993 and 2000 were included. A total of 2,118 patients were eligible for analysis. HPV DNA sequences were detected in 96?6% of the specimens, among which 82% harbored single-type and 18% contained multiple-type HPV sequences. Th e leading 5 were: HPV16 (50?0%), HPV18 (17?8%), HPV58 (16?3%), HPV33 (8?7%), and HPV52 (6?8%). Th e relation of HPV genotype to prognosis of invasive cervical cancer has been controversial. Our study off ered a conclusion on (n=1067) this issue. By multivariate analysis, FIGO stage, lymph node metastasis, depth of cervical stromal invasion, grade of diff erentiation, and HPV 18-positivity were signifi cantly related to cancer relapse. FIGO stage II, deep stromal invasion, parametrial extension, HPV 18-positivity, and age older than 45 were signifi cant predictors for death. Using the seven selected variables from either recurrence-free or overall survival analysis, death and relapse predicting models classifying three risk groups (low-risk, intermediate-risk, and high-risk) were constructed and endorsed by internal validation. Th e prognostic models could be useful in counseling patients and stratifying subjects in future clinical trials. Among the 992 patients treated with primary radiotherapy, the high-risk group consisted of the patients without HPV infection or the ones infected with the alpha-7 species only in addition to stage, lymph node metastasis, histologic type and squamous cell carcinoma antigen.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Antivirals & Antiretrovirals
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chyong-Huey Lai”
